The leader of the Great Moldova Party, Victoria Furtună, has submitted an official request to Moldova’s Ministry of Health and the government.
In her appeal, the politician demands the initiation of negotiations with Russian institutions, including the Russian Ministry of Health, the Gamaleya National Research Center for Epidemiology and Microbiology, and the developers of the personalized anti-cancer mRNA vaccine NeoOncovac.
The request is based on official statistics showing that approximately 20,000 people in Moldova are diagnosed with cancer every year, while nearly 9,000 patients die after receiving the diagnosis.
Furtună explained how the Russian vaccine is intended to work. Once cancer is diagnosed, biomaterial is taken from the affected area and used to create an individualized treatment. According to her, successful cases of cancer treatment using this technology have already been reported in the Russian Federation.
“This is not about geopolitics. It is not about East or West, nor about political preferences. It is about people,” she said while commenting on her request.
Victoria Furtună also noted that numerous everyday goods already enter Moldova from Russia, including mineral fertilizers, food products, medicines, chemical and metallurgical products, coal, construction materials, cardboard, rubber products, and plastics.
“Dear decision-makers, when someone loses their mother, father, child, or life partner to this disease, the last thing that matters is a political dispute. Human life has no political color. And if there is even one additional chance for a cancer patient, the state has a moral obligation to consider it with the utmost seriousness,” Furtună explained.
The politician stressed that she will continue advocating for NeoOncovac to be evaluated for possible procurement and made available to Moldovan cancer patients.
